<DOC>
	<DOCNO>NCT00517426</DOCNO>
	<brief_summary>To evaluate effect CO2 inhalation acetazolamide treatment exercise-induced periodic breathing patient chronic stable heart failure . Patients give CO2 ( 2 % ) constant workload exercise . Patients also evaluate maximal cardiopulmonary exercise test without acetazolamide acute chronic treatment .</brief_summary>
	<brief_title>Effects Acetazolamide CO2 Inhalation Exercise-induced Periodic Breathing Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<criteria>chronic heart failure stable clinical condition exerciseinduced periodic breathing comorbidities NYHA class IV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>heart failure ,</keyword>
	<keyword>exercise</keyword>
	<keyword>periodic breathing ,</keyword>
	<keyword>acetazolamide</keyword>
</DOC>